Literature DB >> 22112740

Analysis of circumferential and longitudinal left ventricular systolic function in patients with non-ischemic chronic heart failure and preserved ejection fraction (from the CARRY-IN-HFpEF study).

Giovanni Cioffi1, Michele Senni, Luigi Tarantini, Pompilio Faggiano, Andrea Rossi, Carlo Stefenelli, Tiziano Edoardo Russo, Selmi Alessandro, Francesco Furlanello, Giovanni de Simone.   

Abstract

Heart failure with preserved left ventricular ejection fraction (HFpEF) is implicitly attributed to diastolic dysfunction, often recognized in elderly patients with hypertension, diabetes, and renal dysfunction. In these patients, left ventricular circumferential and longitudinal shortening is often impaired despite normal ejection fraction. The aim of this prospective study was to analyze circumferential and longitudinal shortening and their relations in patients with nonischemic HFpEF. Stress-corrected midwall shortening (sc-MS) and mitral annular peak systolic velocity (S') were measured in 60 patients (mean age 73 ± 13 years) with chronic nonischemic HFpEF in stable New York Heart Association functional class II or III and compared to the values in 120 healthy controls and 120 patients with hypertension without HFpEF. Sc-MS was classified as low if <89% and S' as low if <8.5 cm/s (the 10th-percentile values of healthy controls). Isolated low sc-MS was detected in 46% of patients with HFpEF, 27% of patients with hypertension, and 2% of controls; isolated low S' was detected in 11% of patients with HFpEF, 7% of patients with hypertension, and 5% of controls; and combined low sc-MS and low S' was detected in 26% of patients with HFpEF, 9% of patients with hypertension, and 5% of controls (HFpEF vs others, all p values <0.001). Thus, any alteration of systolic function was found in 83% of patients with HFpEF. The relation between sc-MS and S' was nonlinear (cubic). Changes in S' within normal values corresponded to negligible variations in sc-MS, whereas the progressive decrease below 8.5 cm/s was associated with substantial decrease in sc-MS. In conclusion, circumferential and/or longitudinal systolic dysfunction is present in most patients with HFpEF. Circumferential shortening normalized by wall stress identifies more patients with concealed left ventricular systolic dysfunction than longitudinal shortening.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22112740     DOI: 10.1016/j.amjcard.2011.09.022

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Combined circumferential and longitudinal left ventricular systolic dysfunction in patients with type 2 diabetes mellitus without myocardial ischemia.

Authors:  Giovanni Cioffi; Giorgio Faganello; Stefania De Feo; Nicola Berlinghieri; Luigi Tarantini; Andrea Di Lenarda; Bruno Pinamonti; Riccardo Candido; Pompilio Faggiano
Journal:  Exp Clin Cardiol       Date:  2013

2.  Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study.

Authors:  Giovanni Cioffi; Ombretta Viapiana; Federica Ognibeni; Andrea Dalbeni; Davide Gatti; Silvano Adami; Carmine Mazzone; Giorgio Faganello; Andre Di Lenarda; Maurizio Rossini
Journal:  Herz       Date:  2015-05-20       Impact factor: 1.443

3.  Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.

Authors:  Amil M Shah; Brian Claggett; Nancy K Sweitzer; Sanjiv J Shah; Inder S Anand; Li Liu; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  Circulation       Date:  2015-06-30       Impact factor: 29.690

Review 4.  New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.

Authors:  Michele Senni; Walter J Paulus; Antonello Gavazzi; Alan G Fraser; Javier Díez; Scott D Solomon; Otto A Smiseth; Marco Guazzi; Carolyn S P Lam; Aldo P Maggioni; Carsten Tschöpe; Marco Metra; Scott L Hummel; Frank Edelmann; Giuseppe Ambrosio; Andrew J Stewart Coats; Gerasimos S Filippatos; Mihai Gheorghiade; Stefan D Anker; Daniel Levy; Marc A Pfeffer; Wendy Gattis Stough; Burkert M Pieske
Journal:  Eur Heart J       Date:  2014-08-07       Impact factor: 29.983

5.  Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction.

Authors:  Angela B S Santos; Elisabeth Kraigher-Krainer; Natalie Bello; Brian Claggett; Michael R Zile; Burkert Pieske; Adriaan A Voors; John J V McMurray; Milton Packer; Toni Bransford; Marty Lefkowitz; Amil M Shah; Scott D Solomon
Journal:  Eur Heart J       Date:  2013-10-27       Impact factor: 29.983

6.  Evaluation of Unattended Automated Office, Conventional Office and Ambulatory Blood Pressure Measurements and Their Correlation with Target Organ Damage in an Outpatient Population of Hypertensives: Study Design and Methodological Aspects.

Authors:  Costantino Mancusi; Francesca Saladini; Giacomo Pucci; Fabio Bertacchini; Valeria Bisogni; Rosa Maria Bruno; Giulia Rivasi; Alessandro Maloberti; Maria Virginia Manzi; Martina Rosticci; Silvia Monticone; Martina de Feo; Rita Del Pinto; Giulio Geraci; Grazia Canciello; Martino Pengo; Gianfranco Parati
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-10-17

7.  Echocardiographic markers of inducible myocardial ischemia at baseline evaluation preparatory to exercise stress echocardiography.

Authors:  Antonella Cherubini; Giovanni Cioffi; Carmine Mazzone; Giorgio Faganello; Giulia Barbati; Luigi Tarantini; Giulia Russo; Carlo Stefenelli; Franco Humar; Eliana Grande; Maurizio Fisicaro; Claudio Pandullo; Andrea Di Lenarda
Journal:  Cardiovasc Ultrasound       Date:  2016-06-01       Impact factor: 2.062

8.  Left ventricular contractile performance and heart failure in patients with left ventricular ejection fraction more than 40.

Authors:  Shuichi Kitada; Yu Kawada; Satoshi Osaga; Marina Kato; Shohei Kikuchi; Kazuaki Wakami; Yoshihiro Seo; Nobuyuki Ohte
Journal:  Heart Vessels       Date:  2020-06-05       Impact factor: 2.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.